Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001193125-25-272572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-07 | 2025-11-05 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $75.36 | -20.0K | 5,587 | -78% | -$1.51M |
| DT | 2025-11-07 | 2025-11-05 | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +20.0K | 25.3K | +378% | +$433.0K |
| DT | 2025-11-07 | 2025-11-05 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -20.0K | 290.0K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | S | D | 300 | $76.28 | 5,287 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-05 | M | A | 20,000 | $21.65 | 25,287 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-05 | S | D | 6,536 | $74.75 | 18,751 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.17 to $75.165 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2025-11-05 | S | D | 13,164 | $75.64 | 5,587 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $75.185 to $76.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 5 | Derivative | Stock option (right to buy) | 2025-11-05 | M | D | 20,000 | $0.00 | 290,000 | D | $21.65 · — to 2031-09-01 | 20,000 Common Stock | (F4) Fully exercisable. |